37.4 F
New York
Thursday, January 20, 2022

New York Times Reports COVID Boosters May Cause ‘Immune System Fatigue’

Related Articles

- Advertisement -

Must read

by Jared Evan Quietly reported in a recent NY Times story pertaining to Israel’s rollout of a 4th COVID vaccine, was startling information which would most likely get one banned from YouTube and discredited as an “anti-vaxer” by the mainstream.

Many individuals, such as  Dr.Robert Malone and Robert F Kennedy Jr.,  who have raised questions about the mRNA vaccines, and are now being censored and maligned.

Experts are now warning that too many injections may cause “immune system fatigue,” and actually compromise the body’s ability to fight the virus, the New York Times reported(LINK).

Dr. Malone and dozens of other “vaccine skeptics”, have repeatedly claimed that the mRNA vaccines are weakening immune systems.

It is quite astonishing the NY Times reported on what is considered a taboo “conspiracy theory”

NY Times reported:

JERUSALEM — Israel is considering whether to approve a fourth Covid-19 vaccine dose for vulnerable people to contain the fast-spreading Omicron variant, despite debate among scientists and a lack of evidence either for or against another booster.
The panel of experts advising the Israeli government on the pandemic recognized that uncertainty, but on Tuesday it recommended giving a fourth dose, concluding that the potential benefits outweighed the risks. It pointed to signs of waning immunity a few months after the third shot, and said that any delay in additional doses might prove too late to protect those most at risk.
But some scientists warned that the plan could backfire, because too many shots might cause a sort of immune system fatigue, compromising the body’s ability to fight the coronavirus. A few members of the government’s advisory panel raised that concern with respect to the elderly, according to a written summary of the discussion obtained by The New York Times.”

 

 

 

 

 

balance of natureDonate

Latest article